Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Huazhuo Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is formulated based on the TCM principles of tonifying the kidney and resolving turbidity (Bushen Huazhuo) to address the underlying pathology of cognitive impairment. The formula is primarily investigated for the treatment of mild to moderate Alzheimer's disease and vascular dementia. Preclinical and clinical studies suggest that it may improve cognitive function by reducing amyloid-beta deposition, inhibiting tau protein hyperphosphorylation, and exerting anti-inflammatory and neuroprotective effects. It is typically administered as an oral granule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Huazhuo Formula.